ARTV · Artiva Biotherapeutics, Inc. · Debt
$6.15
-0.05 (-0.81%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$300.67M
Shares
48.89M
Volume · Oct 23
315.49K
Avg daily vol (3M)
408.49K
Debt Profile
Processing began with filings dated May 8, 2026 · latest terminal result May 8, 2026Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Operating lease liabilities | 2026-06-30 | USD 9,849,000 | 10-Q filed 2026-08-06 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.